Renal function and clinical outcome of patients with cancer-associated venous thromboembolism randomized to receive apixaban or dalteparin. Results from the Caravaggio trial

The effect of renal impairment (RI) on risk of bleeding and recurrent thrombosis in cancer patients treated with direct oral anticoagulants for venous thromboembolism (VTE) is undefined. We ran a prespecified analysis of the randomized Caravaggio study to evaluate the role of RI as a risk factor for...

Descripción completa

Detalles Bibliográficos
Autores principales: Becattini, Cecilia, Bauersachs, Rupert, Maraziti, Giorgio, Bertoletti, Laurent, Cohen, Alexander, Connors, Jean M., Manfellotto, Dario, Sanchez, Antonio, Brenner, Benjamin, Agnelli, Giancarlo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2021
Materias:
Article - Hemostasis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9244816/
https://www.ncbi.nlm.nih.gov/pubmed/34382385
http://dx.doi.org/10.3324/haematol.2021.279072

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9244816/
https://www.ncbi.nlm.nih.gov/pubmed/34382385
http://dx.doi.org/10.3324/haematol.2021.279072

Ejemplares similares